data13F

IOVA – Iovance Biotherapeutics Inc

Held by 1 of 30 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares521,546
Combined reported value$7.7M

IOVA chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Ray Dalio narrow view 0.03 New521,546$7.7MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Ray Dalio narrow view New521,5460.03

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Ray Dalio narrow view New521,5460.03

Reduced: reduced or closed

No tracked investor reduced or closed this position in the last 4 quarters.

History

1 peakQ3 2026: 1 tracked investors
Q1 2018: 1 tracked investorsQ2 2018: 1 tracked investorsQ3 2018: 1 tracked investorsQ4 2018: 1 tracked investorsQ1 2019: 1 tracked investorsQ2 2019: 1 tracked investorsQ3 2019: 1 tracked investorsQ4 2019: 1 tracked investorsQ1 2020: 1 tracked investorsQ2 2020: 1 tracked investorsQ3 2020: 1 tracked investorsQ4 2020: 1 tracked investorsQ1 2021: 1 tracked investorsQ2 2021: 1 tracked investorsQ3 2021: 1 tracked investorsQ4 2021: 1 tracked investorsQ1 2022: 1 tracked investorsQ2 2022: 1 tracked investorsQ3 2022: 1 tracked investorsQ4 2022: 1 tracked investorsQ1 2023: 1 tracked investorsQ2 2023: 1 tracked investorsQ3 2026: 1 tracked investors
20182026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Ray Dalio521.5K–––––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).